Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
scientific article published on 13 February 2020
Author/s
author: Claudine Isaacs, Laura Esserman, Richard Schwab, Hope Rugo, Michelle E Melisko, Minetta C Liu, Judy Boughey, Angela DeMichele, Douglas Yee, Donald H Berry, Kathy S. Albain, Amy Y Clark, Andres Forero-Torres, Tufia C Haddad, Nola M Hylton, Rita Nanda, Jane Perlmutter, William Symmans, Christina Yau, Teresa Helsten, Erica Stringer-Reasor, Erin M Ellis, Nora Jaskowiak, Kathleen Kemmer, Scott Berry, Katherine Steeg, Ruby Singhrao, Gillian L Hirst, Smita Asare, Lajos Pusztai, Adam L Asare, Laura J. van't Veer, Amy Jo Chien
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.